跳至主要内容
临床试验/CTRI/2016/03/006728
CTRI/2016/03/006728招募中未知

A randomized clinical trial to compare the safety and efficacy of Radioiodine ablation as initial treatment modality versus conventional antithyroid drug therapy for Gravesâ?? disease - RIOT (Radioiodine as Initial Option in Treatment)

Department of Internal Medicine0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult males or females, >18yr age with a diagnosis of Gravesâ?? disease ( Hyperthyroidism)
  • Gravesâ?? disease (Hyperthyroidism) defined as raised T4 and/or T3, low TSH with or without hypermetabolic symptoms, diffuse goiter and diffuse increased uptake on Tc99m Pertechnate scan ( >4%)

排除标准

  • Pregnancy/planning pregnancy in next 01 yr, use of Antithyroid drugs, iodine containing drugs, Multinodular goiter, thyroid malignancy/suspicious nodules, significant eye disease, Refusal to give consent

研究者

相似试验